NR4A1 and breast cancer: Studies have demonstrated that breast cancer in men is more often Hormone Receptor (HR) positive when compared to female breast cancer, and its prevalence is similar to that in postmenopausal women, which indicates that breast cancer in men is usually responsive to anti-hormonal therapies like tamoxifen [14].